March 18, 2024, Filed Under: NewsRegister to Senior Scientist: An Unintentional Path to Vaccine Design. April 4, 2024 Thursday, April 4, 2024 12 – 1 pm Register at bit.ly/S4Feb22 or contact Leta Moser for more information. Research improves thousands, if not millions, of peoples’ lives at a time. Join Dell Med’s Health Transformation Research Institute for the Senior Scientist Seminar Series (S4) to learn about the impressive career paths and impactful scientific contributions of Dell Med and UT faculty. Primary Target Audience: Dell Medical School and Ascension trainees, faculty, staff, medical students, UT researchers and the community at large About the Speaker: Jason McLellan, PhD is a professor of Molecular Biosciences and Robert A Welch Chair in Chemistry at the University of Texas at Austin. He researches viral and bacterial proteins, and his work seeks to understand how these proteins are structured, how they function, and factors this into the development of vaccines and potential treatments for deadly pathogens. Recently, his research has led to the development of the first FDA-approved vaccine for respiratory syncytial virus (RSV). He is one of the inventors of a way to engineer a key protein in coronaviruses for use in vaccines. The technology his team developed can be found in many leading vaccines against COVID-19 (Pfizer/BioNTech, Moderna, Johnson & Johnson, and Novavax).
